The Early Ophthalmic Effects of Vatinoxan in Healthy Detomidine‐Sedated Horses
Veterinary Ophthalmology · 2026-07 · 29 (4)
DOI: 10.1111/vop.70206 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Ophthalmology, online erschienen am 03.06.2026. Verfasst von Minna Pauliina Mustikka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Imidazoles, Intraocular Pressure, Quinolizines, Adrenergic alpha-2 Receptor Antagonists. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Finnish Veterinary Foundation (Eläinlääketieteen Tutkimuksen Tukisäätiö), Eläinlääketieteen Tutkimuksen Tukisäätiö.
Abstract (Originalsprache)
Objective
To evaluate the short‐term ophthalmic effects of vatinoxan, a peripherally selective alpha2‐adrenoceptor antagonist, in detomidine‐sedated horses. Animals Studied Seven healthy horses without ophthalmic disease in a randomized, masked, two‐period crossover study design, with a ≥ 7‐day rest period. Procedures After a bilateral palpebral block (lidocaine 40 mg) and baseline data collection, horses received intravenous detomidine (20 μg/kg [DET]) or DET with vatinoxan (200 μg/kg [DET‐VAT]). Intraocular pressure (IOP) was measured from the left eye while tear production (Schirmer tear test −1; STT) and vertical pupil diameter (VPD) were measured from the right eye at pre‐determined intervals until 25 min post‐treatment. Comparisons within and between treatments were analyzed with Student's t ‐tests (for IOP and VPD) or Wilcoxon's Rank Sum tests (for STT) followed by the Holm‐Bonferroni post hoc adjustment.
Results
The overall post‐treatment IOP across time points was lower after DET (15.7 ± 1.9 [mean ± standard deviation] mmHg) than DET‐VAT (16.9 ± 2.0 mmHg) ( p = 0.01). IOP remained significantly ( p < 0.05) lower than baseline after DET for the whole 25 min observational period, while for DET‐VAT the corrected pairwise comparisons to baseline did not reach significance. The median (range) STT increased from baseline 17 (13–25) mm/min to 24 (18–35) mm/min ( p = 0.022) at 25 min after DET and from 18 (11–35) mm/min to 30 (18–35) mm/min ( p = 0.022) after DET‐VAT, respectively. VPD did not differ significantly from baseline after either treatment.
Conclusions
Vatinoxan alleviated detomidine‐associated early decrease in IOP in healthy horses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland.
- Ophthalmology Section, Equine Department, Vetsuisse Faculty, University of Zürich, Zürich, Switzerland.
ORCID-Profile: Minna Pauliina Mustikka, Ninja Pauliina Karikoski, Marja Riitta Raekallio, Elle Sofia Teppo, Simon Anton Pot, Juhana Honkavaara
Förderung
- The Finnish Veterinary Foundation (Eläinlääketieteen Tutkimuksen Tukisäätiö)
- Eläinlääketieteen Tutkimuksen Tukisäätiö
Zitieren
APA
Mustikka, M. P., Karikoski, N. P., Raekallio, M. R., Teppo, E. S., Pot, S. A., & Honkavaara, J. (2026). The Early Ophthalmic Effects of Vatinoxan in Healthy Detomidine‐Sedated Horses. Veterinary Ophthalmology, 29(4). https://doi.org/10.1111/vop.70206
Vancouver
Mustikka MP, Karikoski NP, Raekallio MR, Teppo ES, Pot SA, Honkavaara J. The Early Ophthalmic Effects of Vatinoxan in Healthy Detomidine‐Sedated Horses. Veterinary Ophthalmology. 2026;29(4). doi:10.1111/vop.70206
BibTeX
@article{Mustikka2026,
author = {Mustikka, Minna Pauliina and Karikoski, Ninja Pauliina and Raekallio, Marja Riitta and Teppo, Elle Sofia and Pot, Simon Anton and Honkavaara, Juhana},
title = {The Early Ophthalmic Effects of Vatinoxan in Healthy Detomidine‐Sedated Horses},
journal = {Veterinary Ophthalmology},
year = {2026},
volume = {29},
number = {4},
doi = {10.1111/vop.70206}
}
EUVIMED